Inspire Investing, LLC Horizon Therapeutics Public LTD CO Transaction History

Inspire Investing, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$98.98 - $115.74 $312,281 - $365,159	3,155 New	3,155 $365,000
Q1 2023 Apr 24, 2023	BUY	$107.32 - $113.5 $45,932 - $48,578	428 Added 14.26%	3,429 $374,000
Q4 2022 Jan 26, 2023	SELL	$62.39 - $113.8 $106,499 - $194,256	-1,707 Reduced 36.26%	3,001 $0
Q3 2022 Nov 07, 2022	BUY	$58.92 - $84.67 $277,395 - $398,626	4,708 New	4,708 $291,000
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $867,127 - $1.27 Million	-10,921 Closed	0 $0

Q1 2022 Apr 21, 2022	SELL	$86.42 - $109.81 $42,259 - $53,697	-489 Reduced 4.29%	10,921 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $1.12 Million - $1.37 Million	11,410 New	11,410 $1.23 Million
Q4 2021 Feb 03, 2022	SELL	$98.56 - $119.91 $1.38 Million - $1.68 Million	-14,022 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $429,587 - $515,869	4,674 Added 50.0%	14,022 $1.54 Million
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $248,371 - $276,249	2,880 Added 44.53%	9,348 $875,000
Q1 2021 Apr 30, 2021	BUY	$71.83 - $95.48 $105,087 - $139,687	1,463 Added 29.23%	6,468 $595,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $335,335 - $422,371	5,005 New	5,005 $366,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.